Exploring the potential of dry powder inhalers as a revolutionary approach to tuberculosis treatment through targeted pulmonary drug delivery.
Breakthrough DNA sensor technology detects live mycobacteria with unprecedented speed and accuracy, revolutionizing TB diagnosis worldwide.